Anticoagulation in cirrhosis

Liver International

Volumn 32, Issue 6, 2012, Pages 878-879

  Villa, Erica ^a   De Maria, Nicola ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NADROPARIN;

ANTICOAGULANT THERAPY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; LIVER CIRRHOSIS; LIVER FUNCTION; PORTAL VEIN THROMBOSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT OUTCOME;

ANTICOAGULANTS; BLOOD COAGULATION; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; MALE; PORTAL VEIN; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; VENOUS THROMBOSIS;

EID: 84861977641     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02825.x     Document Type: Editorial

References (20)

1. Primignani M. Portal vein thrombosis, revisited. Digestive and Liver Disease 2010; 42: 163-170.
2. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 553-8.
3. Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009; 137: 2105-11.
4. De Pietri L, Montalti R, Begliomini B, et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol 2010; 27: 608-16.
5. Okuda K, Ohnishi K, Kimura K, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985; 89: 279-86.
6. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54: 691-7.
7. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-41.
8. Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51: 682-9.
9. Wang J, Zhao H, Liu Y. Portal vein thrombosis. HBPD INT 2005; 4: 515-8.
10. Hoekstra J, Janssen HLA. Vascular liver disorders (II): portal vein thrombosis. Neth J Med 2009; 67: 46-53.
11. Zhang D, Hao J, Yang N. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. J Gastroenterol Hepatol 2010; 25: 116-21.
12. Fisher NC, Wilde JT, Roper J, Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut 2000; 46: 534-9.
13. Mangia A, Villani MR, Cappucci G, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005; 17: 745-51.
14. Plessier A, Denninger M, Consigny Y, et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int 2003; 23: 440-8.
15. Arcadipane A, Nadalin S, Gruttadauria S, et al. The recipient with portal thrombosis and/or previous surgery. Transpl Proc 2008; 40: 1183-6.
16. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49: 1729-64.
17. Senzolo M, M Sartori T, Rossetto V, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012; 32: 919-27.
18. Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein throm-bosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006; 23: 767-75.
19. Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51: 210-18.
20. Villa E, Zecchini R, Marietta M, et al. Enoxaparin pre- vents portal vein thrombosis and decompensation in advanced cirrhotic patients: final report of a prospective randomized controlled study. Hepatology 2011; 54: 418 A.